KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $1.82.

  • West Pharmaceutical Services' EPS (Weighted Average and Diluted) rose 224.72% to $1.82 in Q4 2025 from the same period last year, while for Dec 2025 it was $6.79, marking a year-over-year increase of 149.48%. This contributed to the annual value of $6.79 for FY2025, which is 149.48% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' EPS (Weighted Average and Diluted) stood at $1.82, which was up 224.72% from $1.92 recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' EPS (Weighted Average and Diluted) registered a high of $2.48 during Q2 2022, and its lowest value of $1.23 during Q1 2025.
  • Over the past 5 years, West Pharmaceutical Services' median EPS (Weighted Average and Diluted) value was $1.85 (recorded in 2023), while the average stood at $1.89.
  • As far as peak fluctuations go, West Pharmaceutical Services' EPS (Weighted Average and Diluted) surged by 11192.66% in 2021, and later tumbled by 3116.88% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' EPS (Weighted Average and Diluted) stood at $1.89 in 2021, then decreased by 27.51% to $1.37 in 2022, then soared by 33.58% to $1.83 in 2023, then dropped by 2.73% to $1.78 in 2024, then rose by 2.25% to $1.82 in 2025.
  • Its EPS (Weighted Average and Diluted) was $1.82 in Q4 2025, compared to $1.92 in Q3 2025 and $1.82 in Q2 2025.